| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study
|
Xie, Jiarong
|
|
|
17 |
5 |
p. 1182-1191
|
artikel
|
| 2 |
Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study
|
Lv, Yong
|
|
|
17 |
5 |
p. 1192-1204
|
artikel
|
| 3 |
Consensus on the tertiary prevention of primary liver cancer
|
Nan, Yuemin
|
|
|
17 |
5 |
p. 1057-1071
|
artikel
|
| 4 |
Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure
|
Murakami, Serami
|
|
|
17 |
5 |
p. 1326
|
artikel
|
| 5 |
Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes
|
Vaz, Karl
|
|
|
17 |
5 |
p. 1082-1097
|
artikel
|
| 6 |
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B
|
Huang, Shang-Chin
|
|
|
17 |
5 |
p. 1139-1149
|
artikel
|
| 7 |
Endoscopic band ligation is safe despite low platelet count and high INR
|
Pfisterer, Nikolaus
|
|
|
17 |
5 |
p. 1205-1214
|
artikel
|
| 8 |
Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis
|
Zhang, Wenyan
|
|
|
17 |
5 |
p. 1170-1181
|
artikel
|
| 9 |
Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark?
|
Anirvan, Prajna
|
|
|
17 |
5 |
p. 1318-1319
|
artikel
|
| 10 |
HBV, antivirals, and immunoglobulins after liver transplantation: all that glitters is not gold
|
Giannini, Edoardo G.
|
|
|
17 |
5 |
p. 1324-1325
|
artikel
|
| 11 |
HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence
|
Roche, Bruno
|
|
|
17 |
5 |
p. 1072-1074
|
artikel
|
| 12 |
Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure
|
Kulkarni, Anand V.
|
|
|
17 |
5 |
p. 1233-1240
|
artikel
|
| 13 |
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes
|
Song, Zimin
|
|
|
17 |
5 |
p. 1300-1317
|
artikel
|
| 14 |
High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis
|
Sheng, Li-Ping
|
|
|
17 |
5 |
p. 1113-1124
|
artikel
|
| 15 |
Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
|
Guan, Renguo
|
|
|
17 |
5 |
p. 1279-1288
|
artikel
|
| 16 |
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study
|
Yang, Shi-Ye
|
|
|
17 |
5 |
p. 1251-1264
|
artikel
|
| 17 |
Liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver disease
|
Wang, Zhengyi
|
|
|
17 |
5 |
p. 1162-1169
|
artikel
|
| 18 |
Management of adults with Alagille syndrome
|
Ayoub, Mohammed D.
|
|
|
17 |
5 |
p. 1098-1112
|
artikel
|
| 19 |
Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B
|
Fu, Yu-Long
|
|
|
17 |
5 |
p. 1125-1138
|
artikel
|
| 20 |
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma
|
Saeki, Issei
|
|
|
17 |
5 |
p. 1289-1299
|
artikel
|
| 21 |
Mixed mode of artificial liver support in patients with acute-on-chronic liver failure: a retrospective cohort study
|
Wang, Xiao-hao
|
|
|
17 |
5 |
p. 1241-1250
|
artikel
|
| 22 |
Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan
|
Oyama, Atsushi
|
|
|
17 |
5 |
p. 1215-1224
|
artikel
|
| 23 |
Prospects for treatment of esophageal varices considering the safety of endoscopic band ligation
|
Katsumi, Tomohiro
|
|
|
17 |
5 |
p. 1079-1081
|
artikel
|
| 24 |
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study
|
Wong, Yu Jun
|
|
|
17 |
5 |
p. 1150-1161
|
artikel
|
| 25 |
Reply to: “developing real‑world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond”
|
Hatanaka, Takeshi
|
|
|
17 |
5 |
p. 1320-1321
|
artikel
|
| 26 |
Response to: “Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues”
|
Yang, Shi-Ye
|
|
|
17 |
5 |
p. 1322-1323
|
artikel
|
| 27 |
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure
|
Murakami, Serami
|
|
|
17 |
5 |
p. 1225-1232
|
artikel
|
| 28 |
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1
|
Hu, Jie
|
|
|
17 |
5 |
p. 1265-1278
|
artikel
|
| 29 |
Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis B
|
Faure-Dupuy, Suzanne
|
|
|
17 |
5 |
p. 1075-1078
|
artikel
|
Tijdschrift beschrijving